Breastfeeding Success With the Use of the WHO Syringe Technique for Management of Inverted Nipples in Lactating Women

February 26, 2022 updated by: Mona Nabulsi, American University of Beirut Medical Center

Breastfeeding Success With the Use of the WHO Syringe Technique for Management of Inverted Nipples in Lactating Women: a Study Protocol for a Randomized Controlled Trial

Breastfeeding is the ideal infant nutrition recommended by governmental and medical professional organizations. Yet, women with inverted nipples often face difficulties in breastfeeding that ultimately force them to prematurely terminate breastfeeding. This open-label randomized clinical trial aims to investigate the effectiveness of the use of the inverted syringe technique on exclusive breastfeeding success in women with inverted nipples, as compared to standard of care.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Breastfeeding is the ideal infant nutrition recommended by governmental and medical professional organizations. Its benefits to infants and their mothers are many including protection from infections, certain malignancies and chronic diseases, as well as improved growth, development, cognition and intelligence for children. Yet, women with inverted nipples often face difficulties in breastfeeding that ultimately force them to prematurely terminate breastfeeding. The main treatment of severely inverted nipples is surgical sectioning of the lactiferous ducts at the expense of breast's function. Several conservative measures have also been used for the less severe (grades 1 and 2) inverted nipples such as application of Hoffman Exercises and Woolwich Breast Shields, which have failed to prove their worth. The modified syringe technique is a conservative means for the correction of inverted nipples that was reported in a single case series of 8 women, with high success rates in infant latching (7/8) and exclusive breastfeeding (6/8). It is a simple, inexpensive, portable, safe, and easily learned method that can be performed by mothers as often as required.

This open-label randomized clinical trial aims to investigate the effectiveness of the use of inverted syringe on the 1-month exclusive breastfeeding rate in women with inverted nipples. We hypothesize that in women with grades 1 and 2 inverted nipples, the use of the modified syringe technique soon after delivery, as opposed to the standard of care, will significantly improve breastfeeding rates at 1 month postpartum. We will recruit 100 healthy women at ≥37 weeks of gestation with grades 1 or 2 inverted nipples from the Women's Health Center and the obstetrics outpatient department at AUBMC. They will be randomly allocated to a control group (standard of care) or to the intervention group (inverted syringe). Data will be collected at baseline (socio-demographic variables, inverted nipple grading) and at 1, 3, and 7 days postpartum about infant feeding method, and adverse events. Mothers will be contacted at 1, 3 and 6 months regarding infant feeding method, maternal satisfaction, infant's weight gain and adverse events. The association between breastfeeding success at 1 month and the use of the inverted syringe will be investigated using multivariate regression models. Findings from this study, if positive, will provide much needed evidence for a safe, affordable, readily available and simple intervention to treat inverted nipples and improve breastfeeding practice among affected women.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beirut, Lebanon
        • American University of Beirut Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Healthy pregnant women in their 37th week of gestation or more with grade 1 or 2 inverted nipples
  2. Able to read and write
  3. Singleton or twin pregnancy An inverted nipple is defined as a condition in which the nipple is pulled inward into the breast instead of pointing outward, classified according to Han and Hong [11].

Exclusion Criteria:

  1. Women with grade 3 inverted nipples
  2. Previous breast surgery affecting the breast anatomy
  3. High risk pregnancies
  4. Medical conditions that could interfere with breastfeeding such as critical maternal condition
  5. Newborns with congenital malformations that may interfere with breastfeeding such as esophageal atresia, cleft lip &/or palate
  6. Women choosing artificial milk as their preferred infant nutrition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Inverted syringe
Participants in this arm will use of the inverted syringe before each breastfeeding starting from the first feed after delivery and continued as long as needed by the mother.
Application of mild suction over the mother's inverted nipple using an inverted syringe before each breastfeeding.
No Intervention: Standard of care
Participants in the control group will receive standard medical care as dictated by their obstetricians. Any advice regarding infant nutrition or treatment of inverted nipples will be left to the primary physician, including possible use of the inverted syringe technique. .

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
One month exclusive breastfeeding rate
Time Frame: 1 month postpartum
Proportion of mothers who are exclusively breastfeeding
1 month postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3-month exclusive breastfeeding rate
Time Frame: 3 months postpartum
Proportion of mothers who are exclusively breastfeeding
3 months postpartum
6-month exclusive breastfeeding rate
Time Frame: 6 months postpartum
Proportion of mothers who are exclusively breastfeeding
6 months postpartum
Nipple eversion rate
Time Frame: 1 month postpartum
Proportion of mothers with everted nipples
1 month postpartum
Successful latching
Time Frame: 1 month postpartum
Proportion of infants with successful latching while breastfeeding
1 month postpartum
1-month mixed feeding rate
Time Frame: 1 month postpartum
Proportion of infants on mixed feeding
1 month postpartum
3-month mixed feeding rate
Time Frame: 3 months postpartum
Proportion of infants on mixed feeding
3 months postpartum
6-month mixed feeding rate
Time Frame: 6 months postpartum
Proportion of infants on mixed feeding
6 months postpartum
Breastfeeding-associated complications
Time Frame: 1 week postpartum
Rate of breastfeeding-associated complications such as sore nipple, mastitis, pain, bleeding, breast engorgement
1 week postpartum
Breastfeeding-associated complications
Time Frame: 1 month postpartum
Rate of breastfeeding-associated complications such as sore nipple, mastitis, pain, bleeding, breast engorgement
1 month postpartum
Breastfeeding-associated complications
Time Frame: 3 months postpartum
Rate of breastfeeding-associated complications such as sore nipple, mastitis, pain, bleeding, breast engorgement
3 months postpartum
Breastfeeding-associated complications
Time Frame: 6 months postpartum
Rate of breastfeeding-associated complications such as sore nipple, mastitis, pain, bleeding, breast engorgement
6 months postpartum
Maternal satisfaction with breastfeeding
Time Frame: 1 week postpartum
Maternal satisfaction with breastfeeding assessed with the validated Maternal Breastfeeding Evaluation Scale (MBFES). The scale measures the overall maternal perceived quality with the breastfeeding experience. The scale has a Cronbach's alpha of 0.93. It is composed of 3 subscales: maternal enjoyment/role attainment, infant satisfaction/growth and lifestyle/body image. The corresponding Cronbach's alphas of the subscales are 0.93, 0.88 and 0.80 respectively. The overall score may range from 30 (least satisfied) to 150 (most satisfied).
1 week postpartum
Maternal quality of life
Time Frame: 1 month postpartum
Maternal quality of life assessed with the validated Postpartum Quality of Life instrument
1 month postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Actual)

February 25, 2020

Study Completion (Actual)

July 15, 2020

Study Registration Dates

First Submitted

May 8, 2018

First Submitted That Met QC Criteria

May 8, 2018

First Posted (Actual)

May 18, 2018

Study Record Updates

Last Update Posted (Actual)

March 2, 2022

Last Update Submitted That Met QC Criteria

February 26, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PED.MN.15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Sharing of anonymized IPD is possible upon request from the principal investigator after 1 year from publication of the study.

IPD Sharing Time Frame

After December 2021.

IPD Sharing Access Criteria

Request data sharing from the principal investigator.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breastfeeding

Clinical Trials on Inverted syringe

3
Subscribe